Geriatria

Atualização de prática clínica da AGA sobre suspensão de inibidores de bomba de prótons.

22 Fev, 2022 | 15:45h

AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review – Gastroenterology

Conteúdos relacionados:

Deprescribing proton pump inhibitors guideline

Review: Deprescribing Proton Pump Inhibitors

---

Diretriz prática | Prevenção de lesões por pressão no posicionamento e na mobilização de pacientes na UTI.

22 Fev, 2022 | 15:31h

The prevention of pressure injuries in the positioning and mobilization of patients in the ICU: a good clinical practice document by the Italian Society of Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI) – Journal of Anesthesia, Analgesia and Critical Care

---

Revisão | “Long COVID”: sequelas pós-agudas de COVID-19 com foco cardiovascular.

22 Fev, 2022 | 14:49h

Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus – European Heart Journal

Comunicado de imprensa: Review highlights impact of Long COVID on cardiovascular system – University of Oxford

Conteúdos relacionados:

The pathogenesis and long-term consequences of Covid-19 cardiac injury: state-of-the-art review.

COVID-19 infections increase risk of heart conditions up to a year later, study finds.

---

Revisão | Lesão cerebral traumática aguda em pacientes frágeis: a próxima pandemia.

22 Fev, 2022 | 14:28h

Acute traumatic brain injury in frail patients: the next pandemic – Current Opinion in Critical Care

---

Ponto de vista | Como atingir a excelência diagnóstica para pacientes idosos.

19 Fev, 2022 | 13:48h

Achieving Diagnostic Excellence for Older Patients – JAMA (gratuito por tempo limitado)

---

Revisão sistemática | Comprometimento visual e declínio cognitivo entre idosos.

19 Fev, 2022 | 13:33h

Vision impairment and cognitive decline among older adults: a systematic review – BMJ Open

---

Metanálise mostra que a prevalência geral de intolerância à estatina é de cerca de 9% e identifica os fatores de risco mais comuns.

17 Fev, 2022 | 15:31h

Prevalence of statin intolerance: a meta-analysis – European Heart Journal

Comentários:

Study shows the true prevalence of statin intolerance worldwide is between 6 to 10% – News Medical / European Society of Cardiology

Expert reaction to study looking at statin intolerance – Science Media Centre

Conteúdos relacionados:

Side effect patterns in a crossover trial of statin, placebo, and no treatment – This N-of-1 trial, now published in full, suggests the nocebo effect causes most of statins muscle adverse effects.

#AHA20 – In patients who had discontinued statins because of side effects, a N-of-1 trial of a statin, placebo, or no treatment found that side effects often attributed to statins were the same for those taking a placebo

 

Comentário no Twitter

Statin intolerance is “over-estimated and over-diagnosed”. World’s largest study shows less than 10% suffer side-effects caused by statins https://t.co/pcVk8YI3I3@escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes #CVD #Riskfactors pic.twitter.com/b3nFWsc74d

— European Society of Cardiology Journals (@ESC_Journals) February 16, 2022

 

---

Estudo clínico randomizado por cluster | Um sistema eletrônico de apoio à tomada de decisão para fazer deprescrições para idosos internados foi seguro e melhorou a deprescrição, mas não reduziu os eventos adversos relacionados a medicamentos.

15 Fev, 2022 | 11:30h

The MedSafer Study—Electronic Decision Support for Deprescribing in Hospitalized Older Adults: A Cluster Randomized Clinical Trial – JAMA Internal Medicine

 

Comentário no Twitter

Randomized control trial found that @MedSaferTool increases #deprescribing by 22% at hospital discharge but little impact on short term adverse drug events. https://t.co/XqiSwFSPEz @DrEmilyMcD @DrToddLee @DeprescribeUS

— JAMA Internal Medicine (@JAMAInternalMed) January 18, 2022

 

---

Diretriz ERS | Seguimento de “long COVID-19”.

14 Fev, 2022 | 16:11h

European Respiratory Society Statement on Long COVID-19 Follow-Up – European Respiratory Review

---

Avaliação e tratamento da hipotensão ortostática: dados limitados, oportunidades ilimitadas.

11 Fev, 2022 | 13:48h

Evaluation and management of orthostatic hypotension: Limited data, limitless opportunity – Cleveland Clinic Journal of Medicine

---